Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sumitomo Dainippon Pharma Co ( (JP:4506) ) just unveiled an update.
Sumitomo Pharma Co., Ltd. reported a significant finance income for the third quarter of the fiscal year ending March 31, 2025, driven by a foreign exchange gain of 14,975 million yen due to currency fluctuations affecting its overseas subsidiaries. This financial development reflects positively on the company’s financial health and can potentially enhance its competitive positioning in the pharmaceutical industry.
More about Sumitomo Dainippon Pharma Co
Sumitomo Pharma Co., Ltd. is a pharmaceutical company based in Osaka, Japan. It is involved in the development, manufacturing, and marketing of pharmaceutical products and operates in the global market.
YTD Price Performance: 5.62%
Average Trading Volume: 3,845
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.48B
Learn more about 4506 stock on TipRanks’ Stock Analysis page.